The Potential of Induced Pluripotent Stem Cells to Advance the Treatment of Pancreatic Ductal Adenocarcinoma by Ricki T. Krog, Noel F. C. C. de Miranda, Alexander L. Vahrmeijer, Nigel G. Kooreman

Get full text

415 Both allogeneic and syngeneic induced pluripotent stem cell (iPSC) vaccines decrease tumor growth and improve survival in a prophylactic mouse model of breast cancer by Matthias Hundt, Ivan Hernandez, Pratima Kundu, Sahil Inamdar, Carlos A Obejero-Paz, Nigel G Kooreman, Stephen D Wolpe, Lynne A Bui, Skylar R Foust

414 Efficacy and immunogenicity of induced pluripotent stem cell (iPSC) vaccine is independent of iPSC viability in a prophylactic mouse model of breast cancer by Hui Huang, Matthias Hundt, Ivan Hernandez, Pratima Kundu, Sahil Inamdar, Hong Dai, Carlos A Obejero-Paz, Nigel G Kooreman, Stephen D Wolpe, Lynne A Bui

Alloimmune Responses of Humanized Mice to Human Pluripotent Stem Cell Therapeutics by Nigel G. Kooreman, Patricia E. de Almeida, Jonathan P. Stack, Raman V. Nelakanti, Sebastian Diecke, Ning-Yi Shao, Rutger-Jan Swijnenburg, Veronica Sanchez-Freire, Elena Matsa, Chun Liu, Andrew J. Connolly, Jaap F. Hamming, Paul H.A. Quax, Michael A. Brehm, Dale L. Greiner, Leonard D. Shultz, Joseph C. Wu

Get full text